1. Home
  2. MATH vs CYBN Comparison

MATH vs CYBN Comparison

Compare MATH & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MATH
  • CYBN
  • Stock Information
  • Founded
  • MATH 2015
  • CYBN 2019
  • Country
  • MATH Hong Kong
  • CYBN Canada
  • Employees
  • MATH N/A
  • CYBN N/A
  • Industry
  • MATH Finance/Investors Services
  • CYBN Pharmaceuticals and Biotechnology
  • Sector
  • MATH Finance
  • CYBN Health Care
  • Exchange
  • MATH Nasdaq
  • CYBN Nasdaq
  • Market Cap
  • MATH 145.4M
  • CYBN 147.4M
  • IPO Year
  • MATH N/A
  • CYBN N/A
  • Fundamental
  • Price
  • MATH $2.67
  • CYBN $5.99
  • Analyst Decision
  • MATH
  • CYBN Strong Buy
  • Analyst Count
  • MATH 0
  • CYBN 3
  • Target Price
  • MATH N/A
  • CYBN $85.00
  • AVG Volume (30 Days)
  • MATH 134.2K
  • CYBN 1.1M
  • Earning Date
  • MATH 12-05-2025
  • CYBN 11-17-2025
  • Dividend Yield
  • MATH N/A
  • CYBN N/A
  • EPS Growth
  • MATH N/A
  • CYBN N/A
  • EPS
  • MATH 0.41
  • CYBN N/A
  • Revenue
  • MATH $44,567,257.00
  • CYBN N/A
  • Revenue This Year
  • MATH N/A
  • CYBN N/A
  • Revenue Next Year
  • MATH N/A
  • CYBN N/A
  • P/E Ratio
  • MATH $6.54
  • CYBN N/A
  • Revenue Growth
  • MATH 165.86
  • CYBN N/A
  • 52 Week Low
  • MATH $0.88
  • CYBN $4.81
  • 52 Week High
  • MATH $4.17
  • CYBN $13.88
  • Technical
  • Relative Strength Index (RSI)
  • MATH 33.33
  • CYBN 43.16
  • Support Level
  • MATH $2.91
  • CYBN $6.86
  • Resistance Level
  • MATH $3.47
  • CYBN $8.00
  • Average True Range (ATR)
  • MATH 0.22
  • CYBN 0.48
  • MACD
  • MATH -0.04
  • CYBN -0.05
  • Stochastic Oscillator
  • MATH 3.53
  • CYBN 10.04

About MATH Metalpha Technology Holding Limited

Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and generates majority of its revenue from Hong Kong.

About CYBN Cybin Inc.

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.

Share on Social Networks: